Form 4: Aerovate Therapeutics CFO Exercises Options and Sells Shares
SEC Form 4 Filing
George A. Eldridge, CFO of Aerovate Therapeutics, executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On April 1, 2024, George A. Eldridge, the Chief Financial Officer and Treasurer of Aerovate Therapeutics, Inc., exercised stock options to acquire 12,495 shares of common stock at a price of $2.14 per share.
- Simultaneously, Eldridge sold 12,495 shares of common stock at a weighted average price of $31.2291 per share, with individual sales prices ranging from $31.00 to $31.75.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 17, 2023.
- Following these transactions, Eldridge directly owns 1,960 shares of Aerovate Therapeutics common stock and holds options for 15,768 shares.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of insider trading activity under a pre-existing plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information. The exercise of options and subsequent sale of shares is a typical wealth management strategy.
Key Dates
| Date | Description |
|---|---|
| 03/17/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 04/02/2021 | Date of grant of employee stock option for 50,850 shares |
| 03/22/2022 | 25% of employee stock option vested |
| 04/01/2024 | Date of transaction: Exercise of stock options and sale of shares |
| 04/03/2024 | Date of signature on the Form 4 filing |
| 04/01/2031 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.